稳定冠心病患者直接抑制XA因子的第一次经验:药理动力学和药理动力学评估
Christopher K Dyke1, Richard C Becker, Neal S Kleiman
1Duke Clinical Research Institute, Durham, NC 27715, USA.
Circulation
|May 22, 2002
概括
这项研究评估了DX-9065a,一种新型XA因子抑制剂,用于稳定冠心病患者. 抗凝剂显示出较少出血的良好的安全性,支持进一步对动脉血症的研究.
科学领域:
- 心血管医学 心血管医学
- 药理学 药理学 是一个学科.
- 血液学 血液学 血液学
背景情况:
- 血生成是动脉血栓形成的关键在动脉硬性斑块破裂后.
- 研究了在标准治疗中稳定冠状动脉疾病的患者.
- DX-9065a是一种新的,直接的,选择性的,可逆的小分子Xa因子抑制剂.
研究的目的:
- 评估DX-9065a.a.的药理动力学,药理动力学和安全性.
- 评估DX-9065a在治疗冠状动脉动脉栓塞方面的潜力.
主要方法:
- 这是一项双盲试验,涉及73名患有稳定冠心病的患者.
- 患者接受了安慰剂或四种体重调整的DX-9065a疗法之一,通过静脉注射玻尿酸和输液.
- 在输液和24小时消除期间收集了血样本.
主要成果:
- 轻微出血,主要是,在包括安慰剂在内的所有组中都发生了类似的情况.
- 血红蛋白,血小板计数,肌素或肝功能测试没有显著变化.
- 血中药物度与抗Xa因子活性,前列血时间和国际正常化比率有很强的相关性.
结论:
- 这标志着在这个患者群体中选择性,可逆性,直接小分子因子Xa抑制剂的首次研究.
- 这些发现为研究XA因子抑制剂在冠状动脉动脉瘤治疗中提供了基础.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect
The pharmacokinetic-pharmacodynamic (PK-PD) relationship describes the intricate link between drug exposure, efficacy, and toxicity, forming the foundation for optimal dosing regimens. This relationship uses mathematical modeling to characterize drug concentration-effect dynamics, ensuring precise therapeutic outcomes.Exposure represents the pharmacokinetic aspect of the PK-PD relationship, denoting the drug amount that elicits a biological response. It is typically quantified by administered...
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
For drugs producing a quantal response, onset occurs when plasma concentration reaches a minimum effective level (Cmin). The drug's action duration depends on how long the plasma concentration remains above Cmin.Two primary factors influence this duration: dose size and the rate of drug removal from the action site. Both depend on the drug's redistribution to poorly perfused tissues and elimination processes. A larger dose promotes rapid onset and prolongs the effect's duration.Consider a...
Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...


